200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 79639-04-6
79639-04-6 | 1H-Pyrrole, 2-nonyl-
CAS No: 79639-04-6 Catalog No: AG00514Z MDL No:
Product Description
Catalog Number:
AG00514Z
Chemical Name:
1H-Pyrrole, 2-nonyl-
CAS Number:
79639-04-6
Molecular Formula:
C13H23N
Molecular Weight:
193.3284
IUPAC Name:
2-nonyl-1H-pyrrole
InChI:
InChI=1S/C13H23N/c1-2-3-4-5-6-7-8-10-13-11-9-12-14-13/h9,11-12,14H,2-8,10H2,1H3
InChI Key:
GPRHFTZHIFMTGJ-UHFFFAOYSA-N
SMILES:
CCCCCCCCCc1ccc[nH]1
Properties
Complexity:
122
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
193.183g/mol
Formal Charge:
0
Heavy Atom Count:
14
Hydrogen Bond Acceptor Count:
0
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
193.334g/mol
Monoisotopic Mass:
193.183g/mol
Rotatable Bond Count:
8
Topological Polar Surface Area:
15.8A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
6.6
Literature
| Title | Journal |
|---|---|
| Antifungal activities of novel non-azole molecules against S. cerevisiae and C. albicans. | European journal of medicinal chemistry 20120101 |
| Biosynthesis of cholesterol and other sterols. | Chemical reviews 20111012 |
| Role of heme and heme-proteins in trypanosomatid essential metabolic pathways. | Enzyme research 20110101 |
| Synthesis and in vitro antifungal activities of new 3-substituted benzopyrone derivatives. | Bioorganic & medicinal chemistry letters 20101201 |
| Susceptibility to five antifungals of Aspergillus fumigatus strains isolated from chronically colonised cystic fibrosis patients receiving azole therapy. | International journal of antimicrobial agents 20100401 |
| Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: Guidelines of the infectious diseases working party of the German Society of Haematology and Oncology. | European journal of cancer (Oxford, England : 1990) 20090901 |
| [Candidemia in an intensive care unit]. | Medicina (Kaunas, Lithuania) 20090101 |
| CYP51: A major drug target in the cytochrome P450 superfamily. | Lipids 20081201 |
| The Candida glabrata putative sterol transporter gene CgAUS1 protects cells against azoles in the presence of serum. | The Journal of antimicrobial chemotherapy 20071201 |
| A new non-azole inhibitor of ABA 8'-hydroxylase: effect of the hydroxyl group substituted for geminal methyl groups in the six-membered ring. | Bioorganic & medicinal chemistry letters 20060615 |
| Voriconazole in the management of nosocomial invasive fungal infections. | Therapeutics and clinical risk management 20060601 |
| Azole and fungicide resistance in clinical and environmental Aspergillus fumigatus isolates. | Medical mycology 20050501 |
| Structure-based de novo design, synthesis, and biological evaluation of non-azole inhibitors specific for lanosterol 14alpha-demethylase of fungi. | Journal of medicinal chemistry 20030213 |
| Management of patients with recurrent vulvovaginal candidiasis. | Drugs 20030101 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.